Kim Sun-Joong, Tang Tianyi, Abbott Marcia, Viscarra Jose A, Wang Yuhui, Sul Hei Sook
Department of Nutritional Sciences and Toxicology, University of California, Berkeley, California, USA.
Endocrinology Program, University of California, Berkeley, California, USA.
Mol Cell Biol. 2016 Jun 29;36(14):1961-76. doi: 10.1128/MCB.00244-16. Print 2016 Jul 15.
The role of AMP-activated protein kinase (AMPK) in promoting fatty acid (FA) oxidation in various tissues, such as liver and muscle, has been well understood. However, the role of AMPK in lipolysis and FA metabolism in adipose tissue has been controversial. To investigate the role of AMPK in the regulation of adipose lipolysis in vivo, we generated mice with adipose-tissue-specific knockout of both the α1 and α2 catalytic subunits of AMPK (AMPK-ASKO mice) by using aP2-Cre and adiponectin-Cre. Both models of AMPK-ASKO ablation show no changes in desnutrin/ATGL levels but have defective phosphorylation of desnutrin/ATGL at S406 to decrease its triacylglycerol (TAG) hydrolase activity, lowering basal lipolysis in adipose tissue. These mice also show defective phosphorylation of hormone-sensitive lipase (HSL) at S565, with higher phosphorylation at protein kinase A sites S563 and S660, increasing its hydrolase activity and isoproterenol-stimulated lipolysis. With higher overall adipose lipolysis, both models of AMPK-ASKO mice are lean, having smaller adipocytes with lower TAG and higher intracellular free-FA levels. Moreover, FAs from higher lipolysis activate peroxisome proliferator-activated receptor delta to induce FA oxidative genes and increase FA oxidation and energy expenditure. Overall, for the first time, we provide in vivo evidence of the role of AMPK in the phosphorylation and regulation of desnutrin/ATGL and HSL and thus adipose lipolysis.
腺苷酸活化蛋白激酶(AMPK)在促进肝脏和肌肉等多种组织中的脂肪酸(FA)氧化方面的作用已得到充分了解。然而,AMPK在脂肪组织的脂解作用和FA代谢中的作用一直存在争议。为了研究AMPK在体内调节脂肪组织脂解作用中的作用,我们通过使用aP2-Cre和脂联素-Cre构建了AMPK的α1和α2催化亚基在脂肪组织中特异性敲除的小鼠(AMPK-ASKO小鼠)。两种AMPK-ASKO基因敲除模型均显示desnutrin/ATGL水平无变化,但desnutrin/ATGL在S406处的磷酸化存在缺陷,从而降低其甘油三酯(TAG)水解酶活性,降低脂肪组织的基础脂解作用。这些小鼠还显示激素敏感性脂肪酶(HSL)在S565处的磷酸化存在缺陷,而在蛋白激酶A位点S563和S660处的磷酸化较高,增加了其水解酶活性和异丙肾上腺素刺激的脂解作用。由于总体脂肪组织脂解作用较高,两种AMPK-ASKO小鼠模型均体型消瘦,脂肪细胞较小,TAG含量较低,细胞内游离FA水平较高。此外,较高脂解作用产生的FA激活过氧化物酶体增殖物激活受体δ,以诱导FA氧化基因并增加FA氧化及能量消耗。总体而言,我们首次提供了体内证据,证明AMPK在desnutrin/ATGL和HSL的磷酸化及调节以及脂肪组织脂解作用中的作用。